Now Corp

PINK:NWPN USA Drug Manufacturers - Specialty & Generic
Market Cap
$672.33K
Market Cap Rank
#51341 Global
#16013 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
--
All Time High
$0.02
About

The Now Corporation engages in development and commercialization of alternative energy technologies, such as wind power and the revitalization of abandoned oil wells. The company offers the exoPOWER windTURBINE System, a proprietary, patent-pending wind turbine technology designed to enhance wind power generation efficiency. The company was founded in 1993 and is headquartered in Portland, Oregon.

Now Corp (NWPN) - Net Assets

Latest net assets as of December 2024: $-34.70 Million USD

Based on the latest financial reports, Now Corp (NWPN) has net assets worth $-34.70 Million USD as of December 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.71 Million) and total liabilities ($36.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-34.70 Million
% of Total Assets -2026.66%
Annual Growth Rate N/A
5-Year Change -1005.58%
10-Year Change N/A
Growth Volatility 305.34

Now Corp - Net Assets Trend (1999–2024)

This chart illustrates how Now Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Now Corp (1999–2024)

The table below shows the annual net assets of Now Corp from 1999 to 2024.

Year Net Assets Change
2024-12-31 $-34.70 Million -284.03%
2023-12-31 $-9.04 Million -7.40%
2022-12-31 $-8.41 Million -549.32%
2021-12-31 $1.87 Million -51.14%
2020-12-31 $3.83 Million +181.40%
2019-12-31 $-4.71 Million -225.23%
2018-12-31 $-1.45 Million -29.34%
2017-12-31 $-1.12 Million -15.10%
2016-12-31 $-972.45K -78.73%
2014-12-31 $-544.09K -100.06%
2013-12-31 $916.04 Million -8.65%
2012-12-31 $1.00 Billion -12.06%
2011-12-31 $1.14 Billion +46960.16%
2007-12-31 $-2.43 Million -849.01%
2006-12-31 $324.89K -80.48%
1999-12-31 $1.66 Million --

Equity Component Analysis

This analysis shows how different components contribute to Now Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 829781300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $6.12 Million %
Total Equity $-34.70 Million 100.00%

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Now Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -9,036,730 to -34,703,973, a change of -25,667,243.
  • Net loss of 2,765,516 reduced equity.
  • Other comprehensive income increased equity by 5,636,585.
  • Other factors decreased equity by 28,538,312.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-2.77 Million -7.97%
Other Comprehensive Income $5.64 Million +16.24%
Other Changes $-28.54 Million -82.23%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Now Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-12-31 $0.00 $0.00 x
2011-12-31 $0.87 $0.00 x
2012-12-31 $0.77 $0.00 x
2013-12-31 $0.70 $0.00 x
2014-12-31 $0.00 $0.00 x
2016-12-31 $0.00 $0.00 x
2017-12-31 $0.00 $0.00 x
2018-12-31 $0.00 $0.00 x
2019-12-31 $-0.01 $0.00 x
2020-12-31 $0.01 $0.00 x
2021-12-31 $0.00 $0.00 x
2022-12-31 $0.00 $0.00 x
2023-12-31 $0.00 $0.00 x
2024-12-31 $-0.01 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Now Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-23.22%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 -170.61% -27.84% 1.44x 4.26x $-3.01 Million
2006 -0.75% 0.00% 0.00x 31.78x $-34.93K
2007 0.00% 1961.62% 0.00x 0.00x $748.27K
2011 -12.10% -547.65% 0.02x 1.24x $-252.86 Million
2012 -13.56% -279.57% 0.03x 1.42x $-237.48 Million
2013 -9.47% -110.64% 0.05x 1.57x $-179.35 Million
2014 0.00% 0.00% 0.00x 0.00x $-569.00K
2016 0.00% 0.00% 0.00x 0.00x $70.02K
2017 0.00% 0.00% 0.00x 0.00x $-141.07K
2018 0.00% 0.00% 0.00x 0.00x $-183.24K
2019 0.00% 0.00% 0.00x 0.00x $-2.79 Million
2020 -33.90% 0.00% 0.00x 8.20x $-1.68 Million
2021 -131.16% 0.00% 0.00x 16.71x $-2.64 Million
2022 0.00% 0.00% 0.00x 0.00x $-1.86 Million
2023 0.00% 0.00% 0.00x 0.00x $-655.33K
2024 0.00% 0.00% 0.00x 0.00x $704.88K

Industry Comparison

This section compares Now Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Now Corp (NWPN) $-34.70 Million -170.61% N/A $0.95
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million